Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-02

AUTHORS

Chandrajit P. Raut, Qian Wang, Judith Manola, Jeffrey A. Morgan, Suzanne George, Andrew J. Wagner, James E. Butrynski, Christopher D. M. Fletcher, George D. Demetri, Monica M. Bertagnolli

ABSTRACT

BACKGROUND: In patients with metastatic gastrointestinal stromal tumor (GIST) on first-line imatinib (IM) undergoing cytoreductive surgery, response to IM at time of surgery correlates with completeness of resection and progression-free and overall survival (PFS, OS). Impact of surgery in IM-resistant patients on second-line sunitinib (SU) is unknown. METHODS: Patients on SU undergoing surgery for metastatic GIST at our institution were reviewed. Response to SU at time of surgery was categorized as responsive disease (RD), limited progression (LP) or generalized progression (GP). RESULTS: Fifty patients underwent surgery after a median 6.7 months of SU. Forty patients (80%) had prior surgery at initial presentation of GIST; 16 (32%) underwent prior surgery on IM. At time of surgery on SU, 10 patients (20%) had RD, 22 (44%) had LP, and 18 (36%) had GP. Resections were macroscopically complete in 25 patients (50%); completeness of resection did not correlate with response to SU. Complication rate was 54%; reoperations were required in 16%. Median PFS after surgery and start of SU was 5.8 and 15.6 months, respectively (median follow-up 15.2 months). Corresponding median OS was 16.4 and 26.0 months, respectively. Differences in PFS and OS based on response to SU were not significant. Younger age was prognostic of survival. CONCLUSION: Surgery is feasible in patients with metastatic GIST on SU, but incomplete resections are frequent and complication rates are high. Relevance of survival rates is difficult to assess given the selection bias. Benefits of surgery should be weighed against symptoms and alternative treatments. More... »

PAGES

407-415

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-009-0784-y

DOI

http://dx.doi.org/10.1245/s10434-009-0784-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051459531

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19898902


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Stromal Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrroles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sunitinib", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Surgery, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raut", 
        "givenName": "Chandrajit P.", 
        "id": "sg:person.0724431476.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724431476.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Biostatistics, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Qian", 
        "id": "sg:person.01142204213.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142204213.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Biostatistics, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manola", 
        "givenName": "Judith", 
        "id": "sg:person.014324353177.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014324353177.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morgan", 
        "givenName": "Jeffrey A.", 
        "id": "sg:person.011104360747.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011104360747.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "George", 
        "givenName": "Suzanne", 
        "id": "sg:person.01232472146.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232472146.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Andrew J.", 
        "id": "sg:person.0657204235.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657204235.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Butrynski", 
        "givenName": "James E.", 
        "id": "sg:person.0656316276.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656316276.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pathology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fletcher", 
        "givenName": "Christopher D. M.", 
        "id": "sg:person.01225265354.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225265354.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Demetri", 
        "givenName": "George D.", 
        "id": "sg:person.0676332412.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676332412.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Surgery, Brigham and Women\u2019s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertagnolli", 
        "givenName": "Monica M.", 
        "id": "sg:person.010520272417.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010520272417.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2007.13.4452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005473546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000236630.93587.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015035879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000236630.93587.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015035879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.4849", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025241941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000242710.36384.1b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029429839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000242710.36384.1b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029429839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.20466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031463816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.20466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031463816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-006-9034-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032109989", 
          "https://doi.org/10.1245/s10434-006-9034-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(06)69446-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032166971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-006-9047-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035624784", 
          "https://doi.org/10.1245/s10434-006-9047-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.05.3439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043071792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.0183", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043471372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-02", 
    "datePublishedReg": "2010-02-01", 
    "description": "BACKGROUND: In patients with metastatic gastrointestinal stromal tumor (GIST) on first-line imatinib (IM) undergoing cytoreductive surgery, response to IM at time of surgery correlates with completeness of resection and progression-free and overall survival (PFS, OS). Impact of surgery in IM-resistant patients on second-line sunitinib (SU) is unknown.\nMETHODS: Patients on SU undergoing surgery for metastatic GIST at our institution were reviewed. Response to SU at time of surgery was categorized as responsive disease (RD), limited progression (LP) or generalized progression (GP).\nRESULTS: Fifty patients underwent surgery after a median 6.7 months of SU. Forty patients (80%) had prior surgery at initial presentation of GIST; 16 (32%) underwent prior surgery on IM. At time of surgery on SU, 10 patients (20%) had RD, 22 (44%) had LP, and 18 (36%) had GP. Resections were macroscopically complete in 25 patients (50%); completeness of resection did not correlate with response to SU. Complication rate was 54%; reoperations were required in 16%. Median PFS after surgery and start of SU was 5.8 and 15.6 months, respectively (median follow-up 15.2 months). Corresponding median OS was 16.4 and 26.0 months, respectively. Differences in PFS and OS based on response to SU were not significant. Younger age was prognostic of survival.\nCONCLUSION: Surgery is feasible in patients with metastatic GIST on SU, but incomplete resections are frequent and complication rates are high. Relevance of survival rates is difficult to assess given the selection bias. Benefits of surgery should be weighed against symptoms and alternative treatments.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-009-0784-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate", 
    "pagination": "407-415", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f521a03d67c5ba8050b7f503f6a8707f6044f3467cfcae0509cd25852caf1225"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19898902"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-009-0784-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051459531"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-009-0784-y", 
      "https://app.dimensions.ai/details/publication/pub.1051459531"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99818_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1245/s10434-009-0784-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-009-0784-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-009-0784-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-009-0784-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-009-0784-y'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      58 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-009-0784-y schema:about N05db4fbd3db24b8d9f71a0138e931a23
2 N070a070c653e4207a5ad6aaa9ff9c7f9
3 N1549b1aedd4b43cca0406bacf3dfcbd2
4 N3fab958b527341668a23b47ad3b1fd47
5 N4569e4a1bde649c1838fd7895014140e
6 N67f4210517cd454aac5b4aec7687eee2
7 N6cd7312c20fd4f58b1f69f2cebf37fb2
8 N7204701fcd23490c8444afd19e23dc15
9 N741dd071e5cc48f0904c0e09a25c62d8
10 N7c08835a3e384dcdba3d56ed593f4247
11 N7edb8f5ba6384a86bb8ea6ae3e38ea7b
12 N9bf1211d9a0246bc8a13b95e3dbc2947
13 Nb58af5623b1f4a2291103077752875fe
14 Nbe5ec8e3975f49949c2c779d942e8407
15 Nc87e257e5e874ca1af6e6f595bca336f
16 Nc93d64a74d0d4281a11c633bd2b65339
17 Nfac92f4ad56949d8a43bcf2b7f3970f5
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Nef11ad4b0ec449538290f44a484fdaca
21 schema:citation sg:pub.10.1245/s10434-006-9034-8
22 sg:pub.10.1245/s10434-006-9047-3
23 https://doi.org/10.1002/jso.20466
24 https://doi.org/10.1016/s0140-6736(06)69446-4
25 https://doi.org/10.1080/01621459.1958.10501452
26 https://doi.org/10.1093/jnci/92.3.205
27 https://doi.org/10.1097/01.sla.0000236630.93587.59
28 https://doi.org/10.1097/01.sla.0000242710.36384.1b
29 https://doi.org/10.1200/jco.2005.05.3439
30 https://doi.org/10.1200/jco.2006.09.0183
31 https://doi.org/10.1200/jco.2007.13.4452
32 https://doi.org/10.1200/jco.2007.15.4849
33 schema:datePublished 2010-02
34 schema:datePublishedReg 2010-02-01
35 schema:description BACKGROUND: In patients with metastatic gastrointestinal stromal tumor (GIST) on first-line imatinib (IM) undergoing cytoreductive surgery, response to IM at time of surgery correlates with completeness of resection and progression-free and overall survival (PFS, OS). Impact of surgery in IM-resistant patients on second-line sunitinib (SU) is unknown. METHODS: Patients on SU undergoing surgery for metastatic GIST at our institution were reviewed. Response to SU at time of surgery was categorized as responsive disease (RD), limited progression (LP) or generalized progression (GP). RESULTS: Fifty patients underwent surgery after a median 6.7 months of SU. Forty patients (80%) had prior surgery at initial presentation of GIST; 16 (32%) underwent prior surgery on IM. At time of surgery on SU, 10 patients (20%) had RD, 22 (44%) had LP, and 18 (36%) had GP. Resections were macroscopically complete in 25 patients (50%); completeness of resection did not correlate with response to SU. Complication rate was 54%; reoperations were required in 16%. Median PFS after surgery and start of SU was 5.8 and 15.6 months, respectively (median follow-up 15.2 months). Corresponding median OS was 16.4 and 26.0 months, respectively. Differences in PFS and OS based on response to SU were not significant. Younger age was prognostic of survival. CONCLUSION: Surgery is feasible in patients with metastatic GIST on SU, but incomplete resections are frequent and complication rates are high. Relevance of survival rates is difficult to assess given the selection bias. Benefits of surgery should be weighed against symptoms and alternative treatments.
36 schema:genre research_article
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N16ffb85a45d449db94de9d1d9038f1a9
40 N2ce5e59a0fb642f3a0f5faee7d31fc77
41 sg:journal.1105545
42 schema:name Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate
43 schema:pagination 407-415
44 schema:productId N00fc81f98fc9443a83262bf995cd8239
45 N31f18f570a8b4444975a02dd17a29ca3
46 N463c7721072b44fb831f4650015efa90
47 N877ed2d90bc54ad6ab133e811198707a
48 Nb6bab1ca9be64956bfeb53278f012786
49 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051459531
50 https://doi.org/10.1245/s10434-009-0784-y
51 schema:sdDatePublished 2019-04-11T09:35
52 schema:sdLicense https://scigraph.springernature.com/explorer/license/
53 schema:sdPublisher N3f9a45dbd46c4aa1af15b5448803369d
54 schema:url http://link.springer.com/10.1245/s10434-009-0784-y
55 sgo:license sg:explorer/license/
56 sgo:sdDataset articles
57 rdf:type schema:ScholarlyArticle
58 N00fc81f98fc9443a83262bf995cd8239 schema:name dimensions_id
59 schema:value pub.1051459531
60 rdf:type schema:PropertyValue
61 N05db4fbd3db24b8d9f71a0138e931a23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Sunitinib
63 rdf:type schema:DefinedTerm
64 N070a070c653e4207a5ad6aaa9ff9c7f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Adult
66 rdf:type schema:DefinedTerm
67 N1549b1aedd4b43cca0406bacf3dfcbd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Indoles
69 rdf:type schema:DefinedTerm
70 N16ffb85a45d449db94de9d1d9038f1a9 schema:issueNumber 2
71 rdf:type schema:PublicationIssue
72 N2b45d42ed09042fc91808550fe6645da schema:name Department of Surgery, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
73 rdf:type schema:Organization
74 N2ce5e59a0fb642f3a0f5faee7d31fc77 schema:volumeNumber 17
75 rdf:type schema:PublicationVolume
76 N317ae68f6a314e7d841bb8321b1c83c7 rdf:first sg:person.01232472146.03
77 rdf:rest N80e2483ee5344607bd9def618670c9ea
78 N31f18f570a8b4444975a02dd17a29ca3 schema:name nlm_unique_id
79 schema:value 9420840
80 rdf:type schema:PropertyValue
81 N3c4ab0ef94624ab3ba93caa28f265e3d schema:name Department of Biostatistics, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
82 rdf:type schema:Organization
83 N3f9a45dbd46c4aa1af15b5448803369d schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 N3fab958b527341668a23b47ad3b1fd47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Protein-Tyrosine Kinases
87 rdf:type schema:DefinedTerm
88 N4555cd3e7d244e5da935845548197231 rdf:first sg:person.011104360747.22
89 rdf:rest N317ae68f6a314e7d841bb8321b1c83c7
90 N4569e4a1bde649c1838fd7895014140e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Female
92 rdf:type schema:DefinedTerm
93 N463c7721072b44fb831f4650015efa90 schema:name pubmed_id
94 schema:value 19898902
95 rdf:type schema:PropertyValue
96 N67f4210517cd454aac5b4aec7687eee2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Male
98 rdf:type schema:DefinedTerm
99 N6cd7312c20fd4f58b1f69f2cebf37fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Treatment Outcome
101 rdf:type schema:DefinedTerm
102 N7204701fcd23490c8444afd19e23dc15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Humans
104 rdf:type schema:DefinedTerm
105 N741dd071e5cc48f0904c0e09a25c62d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Feasibility Studies
107 rdf:type schema:DefinedTerm
108 N7b0a5fd68634483ca7504cdccd9a7ba5 rdf:first sg:person.0656316276.18
109 rdf:rest Nef2061530c1d41f88a8a9b8662b04935
110 N7c08835a3e384dcdba3d56ed593f4247 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Young Adult
112 rdf:type schema:DefinedTerm
113 N7edb8f5ba6384a86bb8ea6ae3e38ea7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Pyrroles
115 rdf:type schema:DefinedTerm
116 N80e2483ee5344607bd9def618670c9ea rdf:first sg:person.0657204235.11
117 rdf:rest N7b0a5fd68634483ca7504cdccd9a7ba5
118 N81c7cf3d81d342febe89c3956715bc88 schema:name Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
119 rdf:type schema:Organization
120 N877ed2d90bc54ad6ab133e811198707a schema:name doi
121 schema:value 10.1245/s10434-009-0784-y
122 rdf:type schema:PropertyValue
123 N88c017fc021647ea8992246528defbf9 schema:name Department of Biostatistics, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
124 rdf:type schema:Organization
125 N940453c6af00437c9992534104687d65 schema:name Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
126 rdf:type schema:Organization
127 N991962c874924008ac563bc07c57cb27 schema:name Department of Surgery, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
128 rdf:type schema:Organization
129 N9bf1211d9a0246bc8a13b95e3dbc2947 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Survival Rate
131 rdf:type schema:DefinedTerm
132 Nb0efb94b39984df994293d826f1f9671 schema:name Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
133 rdf:type schema:Organization
134 Nb58af5623b1f4a2291103077752875fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Antineoplastic Agents
136 rdf:type schema:DefinedTerm
137 Nb6bab1ca9be64956bfeb53278f012786 schema:name readcube_id
138 schema:value f521a03d67c5ba8050b7f503f6a8707f6044f3467cfcae0509cd25852caf1225
139 rdf:type schema:PropertyValue
140 Nb7f84e47aeff478c93820f83ce76de79 schema:name Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
141 rdf:type schema:Organization
142 Nbe2e3ce0be464c5e9a9507abf14de9d9 rdf:first sg:person.01142204213.25
143 rdf:rest Nfe140bedfc5d43a5a110a53bd6ee0b33
144 Nbe5ec8e3975f49949c2c779d942e8407 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Middle Aged
146 rdf:type schema:DefinedTerm
147 Nc87e257e5e874ca1af6e6f595bca336f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Aged
149 rdf:type schema:DefinedTerm
150 Nc93d64a74d0d4281a11c633bd2b65339 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Gastrointestinal Stromal Tumors
152 rdf:type schema:DefinedTerm
153 Ncc0c85afee7347f9997e90696d759b1b schema:name Department of Pathology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
154 rdf:type schema:Organization
155 Ncd891d8d6fae4074878e8d3f4e0d01b5 rdf:first sg:person.0676332412.10
156 rdf:rest Nd56e72b94b314b0494b06db534e4dd1e
157 Nd56e72b94b314b0494b06db534e4dd1e rdf:first sg:person.010520272417.55
158 rdf:rest rdf:nil
159 Ne86c51287f4c4ef5b37c2a54ebbaaf09 schema:name Department of Medical Oncology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
160 rdf:type schema:Organization
161 Nef11ad4b0ec449538290f44a484fdaca rdf:first sg:person.0724431476.35
162 rdf:rest Nbe2e3ce0be464c5e9a9507abf14de9d9
163 Nef2061530c1d41f88a8a9b8662b04935 rdf:first sg:person.01225265354.17
164 rdf:rest Ncd891d8d6fae4074878e8d3f4e0d01b5
165 Nfac92f4ad56949d8a43bcf2b7f3970f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Retrospective Studies
167 rdf:type schema:DefinedTerm
168 Nfe140bedfc5d43a5a110a53bd6ee0b33 rdf:first sg:person.014324353177.49
169 rdf:rest N4555cd3e7d244e5da935845548197231
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
174 schema:name Clinical Sciences
175 rdf:type schema:DefinedTerm
176 sg:journal.1105545 schema:issn 1068-9265
177 1534-4681
178 schema:name Annals of Surgical Oncology
179 rdf:type schema:Periodical
180 sg:person.010520272417.55 schema:affiliation N991962c874924008ac563bc07c57cb27
181 schema:familyName Bertagnolli
182 schema:givenName Monica M.
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010520272417.55
184 rdf:type schema:Person
185 sg:person.011104360747.22 schema:affiliation Ne86c51287f4c4ef5b37c2a54ebbaaf09
186 schema:familyName Morgan
187 schema:givenName Jeffrey A.
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011104360747.22
189 rdf:type schema:Person
190 sg:person.01142204213.25 schema:affiliation N88c017fc021647ea8992246528defbf9
191 schema:familyName Wang
192 schema:givenName Qian
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142204213.25
194 rdf:type schema:Person
195 sg:person.01225265354.17 schema:affiliation Ncc0c85afee7347f9997e90696d759b1b
196 schema:familyName Fletcher
197 schema:givenName Christopher D. M.
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225265354.17
199 rdf:type schema:Person
200 sg:person.01232472146.03 schema:affiliation Nb7f84e47aeff478c93820f83ce76de79
201 schema:familyName George
202 schema:givenName Suzanne
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232472146.03
204 rdf:type schema:Person
205 sg:person.014324353177.49 schema:affiliation N3c4ab0ef94624ab3ba93caa28f265e3d
206 schema:familyName Manola
207 schema:givenName Judith
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014324353177.49
209 rdf:type schema:Person
210 sg:person.0656316276.18 schema:affiliation Nb0efb94b39984df994293d826f1f9671
211 schema:familyName Butrynski
212 schema:givenName James E.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656316276.18
214 rdf:type schema:Person
215 sg:person.0657204235.11 schema:affiliation N940453c6af00437c9992534104687d65
216 schema:familyName Wagner
217 schema:givenName Andrew J.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657204235.11
219 rdf:type schema:Person
220 sg:person.0676332412.10 schema:affiliation N81c7cf3d81d342febe89c3956715bc88
221 schema:familyName Demetri
222 schema:givenName George D.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676332412.10
224 rdf:type schema:Person
225 sg:person.0724431476.35 schema:affiliation N2b45d42ed09042fc91808550fe6645da
226 schema:familyName Raut
227 schema:givenName Chandrajit P.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724431476.35
229 rdf:type schema:Person
230 sg:pub.10.1245/s10434-006-9034-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032109989
231 https://doi.org/10.1245/s10434-006-9034-8
232 rdf:type schema:CreativeWork
233 sg:pub.10.1245/s10434-006-9047-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035624784
234 https://doi.org/10.1245/s10434-006-9047-3
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1002/jso.20466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031463816
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/s0140-6736(06)69446-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032166971
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1097/01.sla.0000236630.93587.59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015035879
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1097/01.sla.0000242710.36384.1b schema:sameAs https://app.dimensions.ai/details/publication/pub.1029429839
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2005.05.3439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043071792
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2006.09.0183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043471372
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1200/jco.2007.13.4452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005473546
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1200/jco.2007.15.4849 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025241941
255 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...